RxDoctor Payments Data

Gregory Ardoin, MD

Foot and Ankle Surgery · Little Rock, ARNPI 1982823217

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medshape, Inc. at 59.9% of the total. Reporting peaked in 2021 at $60,882 and has fallen 54.9% since, to $27,485 in 2025. Among foot and ankle surgery clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$101,048in general payments, 2019–2025

Across 131 payments — averaging $771.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medshape, Inc.$61K
  • Vilex LLC$32K
  • Restor3d, Inc.$3K
  • Zimmer Biomet$1K
  • Stryker$1K
  • Novastep Inc.$848
  • plus $2K from 14 others
$10,985in research payments, 2019–2025

Across 4 payments — averaging $2746.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vilex LLC$11K

What the payments were for

  • Consulting fees$29,18829%
  • Travel & lodging$7,2537%
  • Food & beverage$3,8334%
  • Education$3370%
  • Gifts$3600%
  • Other$60,07759%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$101,048 in reported general payments places this provider in the 95th percentile of 35 foot and ankle surgery providers in Arkansas.

See all foot and ankle surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$335,916
Medicare patients
554
Services billed
3,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen228$2,015
Ondansetron Hcl270$1,972
Diclofenac Sodium17$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$174
Doxycycline Hyclate16$171
Meloxicam29$43

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →